iCell – Immune Cell Therapy of Cancer
The iCell group at the Finnish Red Cross Blood Service is engaged in basic research and translational projects aimed at understanding immune cell characteristics and bringing them toward translation to the clinic as cell therapies. Projects explore both ‘native’ immune cells such as T and NK cells, as well as their genetic modifications.
Mailing address: iCell, Research & Development
Finnish Red Cross Blood Service, Härkälenkki 13, FI-01730 Vantaa, Finland
Emmi Tiilikainen, MSc
Research Assistant in CAR-NK and NK cell research -projects